Geron to Present at the Stifel 2021 Virtual Healthcare Conference
12 November 2021 - 11:30PM
Business Wire
Geron Corporation (Nasdaq: GERN), a late-stage biopharmaceutical
company focused on the development and commercialization of
treatments for hematologic malignancies, today announced that John
A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer,
will present a company overview at the Stifel 2021 Virtual
Healthcare Conference on Tuesday, November 16, 2021 at 2:40 p.m.
ET.
A live webcast of the presentation will be available through the
Investor Relations section of Geron’s website under Events.
Following the presentation, the webcast will be archived and
available for replay for a period of 30 days.
About Geron
Geron is a late-stage clinical biopharmaceutical company focused
on the development and potential commercialization of a
first-in-class telomerase inhibitor, imetelstat, in hematologic
malignancies. The Company currently is conducting two Phase 3
clinical trials: IMerge in lower risk myelodysplastic syndromes and
IMpactMF in refractory myelofibrosis. For more information about
Geron, visit www.geron.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211112005451/en/
Olivia Bloom Chief Financial Officer investor@geron.com
media@geron.com
Geron (NASDAQ:GERN)
Historical Stock Chart
From Apr 2024 to May 2024
Geron (NASDAQ:GERN)
Historical Stock Chart
From May 2023 to May 2024